Coherus Biosciences Inc (NASDAQ: CHRS) stock slightly recovers post a weak session
Coherus Biosciences Inc (NASDAQ: CHRS) stock fell 13.30% on July 8th, 2019 (Source: Google finance) after the company reported preliminary second-quarter 2019 revenue. The developer…
